BiomX Total Liabilities 2019-2024 | PHGE
BiomX total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| BiomX Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $22 |
| 2022 | $24 |
| 2021 | $30 |
| 2020 | $13 |
| 2019 | $8 |
| 2018 | $3 |
| 2017 | $0 |
| BiomX Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $41 |
| 2024-03-31 | $59 |
| 2023-12-31 | $22 |
| 2023-09-30 | $25 |
| 2023-06-30 | $25 |
| 2023-03-31 | $25 |
| 2022-12-31 | $24 |
| 2022-09-30 | $25 |
| 2022-06-30 | $26 |
| 2022-03-31 | $29 |
| 2021-12-31 | $30 |
| 2021-09-30 | $28 |
| 2021-06-30 | $13 |
| 2021-03-31 | $13 |
| 2020-12-31 | $13 |
| 2020-09-30 | $9 |
| 2020-06-30 | $5 |
| 2020-03-31 | $5 |
| 2019-12-31 | $8 |
| 2019-09-30 | $66 |
| 2019-06-30 | $67 |
| 2019-03-31 | $66 |
| 2018-12-31 | |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.014B | $0.000B |
| BiomX Ltd is a clinical stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy bacteria which affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC and cancer. BiomX Ltd, formerly known as Chardan Healthcare Acquisition Corp., is based in Ness Ziona, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $199.131B | 25.32 |
| Stryker (SYK) | United States | $138.494B | 31.22 |
| Boston Scientific (BSX) | United States | $123.686B | 35.59 |
| Medtronic (MDT) | Ireland | $116.063B | 17.27 |
| EssilorLuxottica (ESLOY) | France | $106.208B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.665B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.361B | 32.67 |
| ResMed (RMD) | United States | $35.674B | 29.32 |
| Terumo (TRUMY) | Japan | $28.890B | 40.80 |
| Koninklijke Philips (PHG) | Netherlands | $24.739B | 18.93 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.363B | 13.92 |
| Baxter (BAX) | United States | $18.295B | 12.41 |
| Insulet (PODD) | United States | $16.167B | 68.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.613B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.213B | 31.45 |
| BellRing Brands (BRBR) | United States | $8.635B | 36.51 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.594B | 18.23 |
| ICU Medical (ICUI) | United States | $4.285B | 40.90 |
| TG Therapeutics (TGTX) | United States | $3.891B | 41.20 |
| Haemonetics (HAE) | United States | $3.686B | 18.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.645B | 18.16 |
| Perrigo (PRGO) | Ireland | $3.469B | 10.96 |
| Envista Holdings (NVST) | United States | $3.307B | 24.65 |
| Neogen (NEOG) | United States | $3.157B | 36.42 |
| GN Store Nord (GNNDY) | Denmark | $2.926B | 17.63 |
| Agios Pharmaceuticals (AGIO) | United States | $2.634B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.622B | 16.52 |
| Green Thumb Industries (GTBIF) | United States | $2.133B | 36.00 |
| LeMaitre Vascular (LMAT) | United States | $2.001B | 53.32 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.925B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.917B | 0.00 |
| Warby Parker (WRBY) | United States | $1.723B | 0.00 |
| AtriCure (ATRC) | United States | $1.696B | 0.00 |
| InMode (INMD) | Israel | $1.501B | 9.03 |
| AdaptHealth (AHCO) | United States | $1.448B | 10.46 |
| Verano Holdings (VRNOF) | United States | $1.160B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.057B | 0.00 |
| Owens & Minor (OMI) | United States | $1.022B | 7.89 |
| Capricor Therapeutics (CAPR) | United States | $0.970B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.960B | 19.92 |
| CeriBell (CBLL) | United States | $0.885B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.801B | 25.45 |
| Cresco Labs (CRLBF) | United States | $0.732B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.546B | 16.48 |
| Surmodics (SRDX) | United States | $0.535B | 113.64 |
| Quanterix (QTRX) | United States | $0.513B | 0.00 |
| Valneva SE (VALN) | France | $0.475B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.465B | 0.00 |
| ZimVie (ZIMV) | United States | $0.378B | 31.86 |
| Viemed Healthcare (VMD) | United States | $0.345B | 37.00 |
| Cerus (CERS) | United States | $0.319B | 0.00 |
| Jin Medical (ZJYL) | China | $0.316B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.313B | 8.08 |
| Aurora Cannabis (ACB) | Canada | $0.312B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.304B | 0.00 |
| Zynex (ZYXI) | United States | $0.287B | 60.13 |
| Sanara MedTech (SMTI) | United States | $0.286B | 0.00 |
| Biote (BTMD) | United States | $0.278B | 12.80 |
| Ayr Wellness (AYRWF) | United States | $0.247B | 0.00 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| High Tide (HITI) | Canada | $0.231B | 95.67 |
| Utah Medical Products (UTMD) | United States | $0.223B | 14.99 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
| Brainsway (BWAY) | Israel | $0.166B | 199.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 19.52 |
| TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.115B | 0.00 |
| Veru (VERU) | United States | $0.112B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 24.10 |
| Fonar (FONR) | United States | $0.098B | 10.12 |
| Jushi Holdings (JUSHF) | United States | $0.094B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.086B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.079B | 0.00 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| Safety Shot (SHOT) | United States | $0.063B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.062B | 1.58 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.047B | 0.00 |
| Exagen (XGN) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.029B | 0.00 |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 19.16 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |